FindTrial
Sign In

recording efficacy of l-arginine in improving outcomes in patients with oligohydramnios

Evaluation of efficacy of l-arginine in improving outcomes in patients with oligohydramnios - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/065276
Enrollment
200
Registered
2024-04-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

Interventions

None listed

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: having oligohydramnios and prescribed arginine, singleton pregnancies, oligohydramnios without arginine

Exclusion criteria

Exclusion criteria: multiple pregnancy, PPROM, congenital anomaly, those who dont consent to take part

Design outcomes

Primary

MeasureTime frame
increase in gestational age, increase in AFITimepoint: increase in gestational age, increase in AFI—

Secondary

MeasureTime frame
mode of deliveryTimepoint: 1.5 to 2 years—

Countries

India

Contacts

Public ContactSnehal Anturlikar
snehal.anturlikar@paruluniversity.ac.in9898563319

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026